Related Experiment Video
Updated: Dec 27, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Expression of non-coding RNAs in hematological malignancies
Soudeh Ghafouri-Fard1, Mohammadhosein Esmaeili2, Mohammad Taheri3
1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
With the advent of novel high throughput techniques, an extensive number of non-coding RNAs have been recognized to be involved in the pathogenesis of different types of hematological malignancies. These transcripts are classified according to their length to long non-coding RNAs (lncRNAs) and microRNAs (miRNAs). Expression studies have revealed dysregulation of their expression in leukemia, lymphoma and multiple myeloma. Notably, some miRNAs have been shown to define stem cell features in leukemic cells. Several lncRNAs exert their pathogenic roles via modulation of miRNA expression or function by acting as sponges for these transcripts. Consequently, recognition of the interactive network between lncRNAs and miRNAs would help in revealing the underlying mechanism of cancer. In this review, we summarize the functions and characteristics of tumor-associated lncRNAs and miRNAs as well as their participation in the hematological malignancies. These data might facilitate design of targeted therapies for this kind of malignancy.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Hematopoiesis

